JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265686

Human AZI2 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

AZI2 KO cell line available to order. KO validated by Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 7 bp deletion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Western blot - Human AZI2 knockout HeLa cell line (AB265686)
  • WB

Lab

Western blot - Human AZI2 knockout HeLa cell line (AB265686)

False colour image of Western blot : Anti-AZI2 antibody [EPR14698] - C-terminal staining at 1/5000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab192253 was shown to bind specifically to AZI2. A band was observed at 45 kDa in wild-type HeLa cell lysates with no signal observed at this size in AZI2 knockout cell line ab265686 (knockout cell lysate ab257852). The band observed in the knockout lysate lane below 45 kDa is likely to represent a truncated form of AZI2. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and AZI2 knockout HeLa cell lysates were analysed.First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-AZI2 antibody [EPR14698] - C-terminal (<a href='/en-us/products/primary-antibodies/azi2-antibody-epr14698-c-terminal-ab192253'>ab192253</a>) at 1/5000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

AZI2 CRISPR-Cas9 edited HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human AZI2 knockout HeLa cell line (ab265686)

Lane 3:

HEK-293 cell lysate at 20 µg

Lane 4:

Daudi cell lysate at 20 µg

Predicted band size: 45 kDa

Observed band size: 45 kDa

false

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 7 bp deletion in exon 2

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

Western blot data indicates that the CRISPR gene edit may have resulted in a truncation of the protein of interest. Please see data images.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265686-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265686 Human AZI2 knockout HeLa cell line", "number":"AB265686-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265686-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265686-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265686 Human AZI2 knockout HeLa cell line", "number":"AB265686-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265686-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265686-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265686 Human AZI2 knockout HeLa cell line", "number":"AB265686-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265686-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265686 Human AZI2 knockout HeLa cell line", "number":"AB265686-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
AZI2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

AZI2 also known as Nak-associated protein 1 (NAP1) is a regulatory protein with a molecular mass of about 55 kDa. Its primary role involves interaction with other molecules to help signal transduction in cells. AZI2 mainly express in tissues that are involved in immune responses such as the spleen and lymph nodes. It functions through modulating the activation of signaling pathways critical for cellular responses to various stimuli.
Biological function summary

AZI2 plays an essential role in the immune system. It is part of a signaling complex that includes other proteins such as TANK and TRAF6. This complex contributes to the activation of NF-kB transcription factors. AZI2 is involved in cellular processes like inflammation and response to stress by regulating the activity of NF-kB an important transcription factor. This regulatory activity underlines AZI2's significance in maintaining immune system homeostasis.

Pathways

AZI2 is closely associated with the toll-like receptor (TLR) and TNF receptor signaling pathways. These pathways orchestrate immune cell responses to microbial infections and inflammation. In these pathways AZI2 interacts with proteins like IKK epsilon and TANK to mediate NF-kB activation. These interactions help transduce signals from membrane-bound receptors to the nucleus promoting the expression of immune response genes.

Aberrant AZI2 function can link to autoimmune diseases and certain cancers. Disruption of AZI2-related signaling pathways can lead to improper immune system activation contributing to autoimmune diseases like rheumatoid arthritis. In cancer altered AZI2 expression can affect pathways that control cell survival and proliferation. Through these diseases AZI2 has associations with key regulatory proteins like TRAF3 and TBK1 which play roles in modulating immune responses and cellular growth.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com